002105.SZ
信隆健康
SZSE · Consumer Cyclical · C 制造业 · CN
CNY 5.85
+0.17%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.2B | 1.2B | 1.2B | 963.9M | 1.8B |
| Cost of Revenue | 1.1B | 1.0B | 1.0B | 785.1M | 1.4B |
| Gross Profit | 157.3M | 148.9M | 180.6M | 178.8M | 428.7M |
| Operating Expenses | |||||
| R&D Expense | 41.7M | 41.9M | 42.2M | 45.6M | 56.6M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 77.7M | 78.4M | 90.3M | 91.0M | 108.5M |
| Selling & Marketing Expense | 40.1M | 40.2M | 39.0M | 28.9M | 35.5M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 186.8M | 179.5M | 181.5M | 180.3M | 202.2M |
| Cost and Expenses | 1.3B | 1.2B | 1.2B | 965.4M | 1.6B |
| Operating Income (EBIT) | (73.1M) | (73.1M) | (23.3M) | (7.1M) | 225.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (67.8M) | (67.2M) | (22.9M) | 14.0M | 239.2M |
| Income Tax Expense | (528.4K) | 670.6K | (3.3M) | (2.9M) | 31.7M |
| Bottom Line | |||||
| Net Income | (63.9M) | (64.1M) | (18.9M) | 21.7M | 189.2M |
| Earnings from Cont. Ops | (67.2M) | (67.9M) | (19.5M) | 16.8M | 207.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (63.9M) | (64.1M) | (18.9M) | 21.7M | 189.2M |
| Per Share | |||||
| Basic EPS | (CN¥0.17) | (CN¥0.17) | (CN¥0.05) | CN¥0.06 | CN¥0.52 |
| Diluted EPS | (CN¥0.17) | (CN¥0.17) | (CN¥0.05) | CN¥0.06 | CN¥0.52 |
| Revenue Per Share | CN¥3.19 | CN¥3.23 | CN¥3.27 | CN¥2.66 | CN¥5.01 |
| Shares | |||||
| Basic Shares Outstanding | 388.8M | 368.1M | 364.1M | 361.7M | 364.6M |
| Diluted Shares Outstanding | 388.8M | 368.1M | 364.1M | 361.7M | 364.6M |
| Profitability Metrics | |||||
| EBITDA | — | 6.8M | 48.2M | 52.1M | 282.9M |
| D&A | — | 79.9M | 71.5M | 59.3M | 57.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026